Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

2004 Scientific Articles

2004 Immunization Safety Branch Publications

2004 Peer-Reviewed Journal Articles

  1. Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, Murphy TM, Music S, Niu M, Varricchio F, Vermeer P, Wong EJC and The Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004;22:569-574.
  2. Bonhoeffer J, Kohl KS, Chen RT, Duclos P, Heijbel H, Heininger U, Jefferson T, Loupi E and The Brighton Collaboration. Standardized case definitions of adverse events following immunization (AEFI). Vaccine 2004;22:547-550.
  3. Bonhoeffer J, Vermeer P, Halperin S, Kempe A, Music S, Shindman J, Walop W, and The Brighton Collaboration Persistent Crying Working Group. Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004; 22:587-592.
  4. Bonhoeffer J, Gold MS, Heijbel H, et al. and The Brighton Collaboration HHE Working Group. Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004; 22:563-568.
  5. Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P, and The Brighton Collaboration Seizure Working Group. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22:557-562.
  6. Chen R. Evaluation of Vaccine Safety Post-9/11: Role of Cohort and Case-Control Studies. Vaccine 2004;22:2047-2053.
  7. Freed GL; Clark SJ; Hibbs BH; Santoli JM. Parental vaccine safety concerns.  The experience of pediatricians and family physicians. Am J Prev Med. 2004; 26(1):11-14.
  8. Haber P, Zanardi LR, Chen RT, Mootrey GT, Pless R,  English R, and Niu M and the VAERS Working Group. A Review of  Rotavirus Vaccine Reportsto the Vaccine Adverse Event Reporting System: More than Intussusception Alone?  Pediatrics 2004Apr;113(4):e353-9.
  9. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT. Guillain-Barré syndrome following influenza vaccination. JAMA. 2004; 292(20):2478-81.
    http://www.ncbi.nlm.nih.gov/pubmed/15562126
  10. Kohl KS, Marcy SM, Blum M, Connell Jones M, Dagan R, Hansen J, Nalin D, Rothstein E, and the Brighton Collaboration Fever Working Group. Fever After Immunization: current concepts and improved future scientific understanding. CID 2004 (in press).
  11. Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Connell Jones M, Hansen J, Labadie J, Lee L, Martin BL, O'Brien K, Rothstein E, Vermeer P and The Brighton Collaboration Fever Working Group. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004;22:551-556.
  12. Muetsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, SpyrC, Steffen R. Inactivated intranasal influenza vaccine and the risk of Bell’s Palsy in Switzerland. New Engl J Med 2004;350:896-903.
  13. O’Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, Yu X, Platt R, and Lieu TA.Incidence of Outpatient Visits and Hospitalizations Related to Influenza in Infants and Young Children. Pediatrics 2004; 113: 585-593.
  14. Rothstein E, Kohl KS, Ball L, Halperin SA, Halsey N, Hammer SJ, Heath PT, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W and The Brighton Collaboration Local Reaction Working Group. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22:575-585.
  15. Steinberg EB, Bishop R, Haber P, Dempsey AF, Hoekstra RM, Nelson JM, Ackers M, Calugar A, Mintz ED. Typhoid fever in travelers: who should be targeted for prevention? Clinical Infectious Disease. 2004; 39(2):186-91. Epub 2004 Jul 1.
    http://www.ncbi.nlm.nih.gov/pubmed/15307027
  16. Varricchio F, Iskander J, DeStefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety: information from the Vaccine Adverse Event Reporting System (VAERS). PIDJ 2004:23:287-94.
  17. Zhou WG,  Pool V, Destefano F, Iskander JK, Haber P, Chen RT, and The VAERS Working Group.  Bell’s Palsy After Parenteral Inactivated Influenza Vaccines: Reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Pharmacoepidemiology and Drug Safety 2004 (in press).

2004 Textbook Publications

  1. Chen RT, Davis R, Sheedy KM. Safety of Vaccines. Ch. 49 In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines, 4th edition. Philadelphia: WB Saunders 2004:1557-84.
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #